1404P Clinical characteristics and therapeutics sequences of KRAS G12C metastatic non-small cell lung cancer (mNCSLC) patients treated by sotorasib in the French pre-marketing authorization (MA) early access program (cohort temporary authorization of use, cATU)

Autor: Lena, H., Cadranel, J., Girard, N., Mazieres, J., Curcio, H., Gille, R., Madroszyk Flandin, A-C., Auliac, J.B., Bylicki, O., Rieux, C., Couraud, S., Barlesi, F., Pichon, E., Métivier, A-C., Almotlak, H., Pabst, L., Deldycke, C., Duchemann, B., De Gunten, L., Quantin, X.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S803-S804
Databáze: ScienceDirect